ARTICLE
Volume 10,Issue 4
25 September 2024
Primary Malignant Melanoma of the Larynx: Case Report and Literature Review
Pan Wang ,
Yashan Wu ,
Pei Zhang ,
Yanan Wang
Show Less
1
Department of Pathology, Affiliated Hospital of Hebei University, Baoding 071000, Hebei Province, China,
PAR 2024 , 8(5), 7–10;
https://doi.org/10.26689/par.v8i5.8297
© 2024 by the Authors. Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract
Primary malignant melanoma of the larynx is extremely rare. This paper reports a case of a patient with primary malignant melanoma of the larynx. Preoperative laryngoscopy revealed a cauliflower-like mass in the supraglottic region, and a CT scan of the pharynx suggested laryngeal cancer with cervical lymph node metastasis. The patient underwent a total laryngectomy with lymph node dissection, and postoperative pathology confirmed a malignant melanoma in the supraglottic region of the larynx.
References
Chinese Society of Pathology, Dermatopathology Group of the Chinese Society of Pathology, 2021, Clinical Practice Guidelines for Pathological Diagnosis of Melanoma (2021 Edition). Chinese Journal of Pathology, 50(6): 572–582.
Terada T, Saeki N, Toh K, et al., 2007, Primary Malignant Melanoma of the Larynx: A Case Report and Literature Review. Auris Nasus Larynx, 34(1): 105–110. https://doi.org/10.1016/j.anl.2006.09.027
Wang Y, Yang C, Huo X, 2020, Report of a Case of Primary Glottic Malignant Melanoma of the Larynx. Jilin Medical Journal, 41(7): 1782–1783.
Wang X, Long J, 2017, Research Progress on the Pathogenesis of Melanoma. Chinese Journal of Plastic Surgery, 33(5): 397–400.
Ascierto PA, Kirkwood JM, Grob JJ, et al., 2012, The Role of BRAF V600 Mutation in Melanoma. J Transl Med, 10: 85. https://doi.org/10.1186/1479-5876-10-85
Bai X, Kong Y, Chi Z, et al., 2017, MAPK Pathway and TERT Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 Cases. Clin Cancer Res, 23(20): 6120–6127. https://doi.org/10.1158/1078-0432.CCR-17-0980
Newell F, Kong Y, Wilmott JS, et al., 2019, Whole-Genome Landscape of Mucosal Melanoma Reveals Diverse Drivers and Therapeutic Targets. Nat Commun, 10(1): 3163. https://doi.org/10.1038/s41467-019-11107-x
Hayward NK, Wilmott JS, Waddell N, et al., 2017, Whole-Genome Landscapes of Major Melanoma Subtypes. Nature, 545(7653): 175–180. https://doi.org/10.1038/nature22071
Shoushtari AN, Bao R, Luke JJ, 2020, PD-1 Blockade in Chinese versus Western Patients with Melanoma. Clin Cancer Res, 26(16): 4171–4173. https://doi.org/10.1158/1078-0432.CCR-20-1558
Cojocaru O, Aschie M, Mocanu L, et al., 2015, Laryngeal Primary Malignant Melanoma: A Case Report. Rom J Morphol Embryol, 56(4): 1513–1516.
Reuter VE, Woodruff JM, 1986, Melanoma of the Larynx. Laryngoscope, 96(4): 389–393. https://doi.org/10.1288/00005537-198604000-00010
Rozeman EA, Hoefsmit EP, Reijers ILM, et al., 2021, Survival and Biomarker Analyses from the OpACIN-neo and OpACIN Neoadjuvant Immunotherapy Trials in Stage III Melanoma. Nat Med, 27(2): 256–263. https://doi.org/10.1038/s41591-020-01211-7
Share
Back to top
Bio-Byword Scientific Publishing Pty. Ltd.
We are committed to supporting the scientific community by publishing impactful research and fostering effective communication among scientists. We continuously seek ways to accelerate scientific progress while upholding transparency and open dialogue. Our goal is to make knowledge freely and barrier‑free accessible to all.
Contact us: info@bbwpublisher.com
Level 10, 50 Clarence Street Sydney, NSW 2000 Australia